Frontlight ResearchEarly access
Triple-negative breast cancer trials in United States
172 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Atlanta, Columbus, Falls Church, Grand Rapids, Houston, La Jolla, Mineola, New York, Scottsdale, West Valley City
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 1Taking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Atlanta, Boston, Chicago, Cleveland, Denver, Duarte, Grand Rapids, Houston, Indianapolis, La Jolla, Los Angeles, Nashville, New York, Salt Lake City, San Antonio, St Louis, St. Petersburg, West Valley City
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - Phase 2Not yet taking people in United StatesUS/PA/E Imaging for Early Identification of Tumor Response in Patients With Stage II-III Triple Negative Breast Cancer Receiving Neoadjuvant Immunotherapy and Chemotherapy
- Where
- Atlanta
- Age
- 18 years and over
- People
- 32
- Run by
- Emory University
See details and how to joinNCT07862751 - Phase 2Taking peoplePh2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
- Where
- Houston
- Age
- 18 years and over
- People
- 120
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07407920 - Phase 2Not yet taking people in United StatesDexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer
- Where
- Kansas City, St Louis
- Age
- 18 years and over
- People
- 17
- Run by
- Washington University School of Medicine
See details and how to joinNCT07914309 - Phase 1Taking peopleSystemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
- Where
- Boston, Cincinnati
- Age
- 18 years and over
- People
- 90
- Run by
- Andrew Hantel, MD
See details and how to joinNCT07341867 - Phase 1/2Taking peopleIvermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer and HR+/HER2- Metastatic Breast Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 34
- Run by
- Yuan Yuan
See details and how to joinNCT05318469 - Phase 2Taking peopleFunctional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 80
- Run by
- University of Utah
See details and how to joinNCT05464082 - Phase 1Taking peopleStudy of XB010 in Subjects With Solid Tumors
- Where
- Atlanta, Austin, Chicago, Dallas, Fairfax, Houston, Huntersville, Irvine, Los Angeles, Nashville, Oklahoma City, Orlando, St Louis, The Bronx, Washington D.C.
- Age
- 18 years and over
- People
- 396 worldwide
- Run by
- Exelixis
See details and how to joinNCT06545331 - Phase 3Taking peopleROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Where
- Arlington, Baltimore, Bay Shore, Bend, Burleson, Burlington, Charlotte, Columbia, Dallas, Decatur, Detroit, Florham Park, Fort Myers, Fort Worth, Germantown, Grand Island, Houston, Kansas City, La Jolla, Livingston, Long Branch, Los Alamitos, Los Angeles, Louisville, Mechanicsville, Midlothian, Milwaukee, Nashville, Newark, New Brunswick, New York, O'Fallon, Omaha, Palm Bay, Palo Alto, Pensacola, Portland, Redmond, Richardson, Richmond, Rochester, Royal Oak, Sacramento, Saint Louis Park, Saint Paul, Salem, Santa Barbara, Santa Monica, Somerville, Springdale, Stony Brook, St. Petersburg, Tacoma, The Bronx, The Woodlands, Toms River, Urbana, Weatherford, Westbrook
- Age
- 18 years and over
- People
- 558 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07173751 · EU 2025-521884-12-00 - Phase 1Taking peopleA Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
- Where
- Aurora, Boston, Chicago, Duarte, La Jolla, Nashville, New York
- Age
- 18 years and over
- People
- 52
- Run by
- Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06908928 - Phase 1Taking peopleA Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Where
- Houston, San Antonio, Scottsdale
- Age
- 18 years and over
- People
- 30
- Run by
- SHY Therapeutics
See details and how to joinNCT07705334 - Phase 1/2Taking peopleIntratumoral N17350 in Advanced Solid Tumors
- Where
- Buffalo, Houston, Los Angeles, San Diego, San Francisco
- Age
- 18 years and over
- People
- 275 worldwide
- Run by
- Onchilles Pharma Inc
See details and how to joinNCT07339176 - No phaseTaking peopleProspective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Where
- Durham, San Francisco, The Bronx
- Age
- 18 years and over
- People
- 100
- Run by
- University of California, San Francisco
See details and how to joinNCT06774027 - Phase 1Taking peopleTesting the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
- Where
- Boston, St Louis
- Age
- 18 years and over
- People
- 36
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07137416 - Phase 2Not yet taking people in United StatesA Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden
- Where
- Seattle
- Age
- 18 years and over
- People
- 60
- Run by
- University of Washington
See details and how to joinNCT07721259 - No phaseTaking peopleA Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- Where
- Arcadia, Duarte, Huntington Beach, Irvine, Lancaster, Long Beach, Santa Clarita, Simi Valley, South Pasadena, Upland, West Covina
- Age
- 18 years and over
- People
- 126
- Run by
- City of Hope Medical Center
See details and how to joinNCT07741968 - Phase 1/2Taking peopleSMP-3124LP in Adults With Advanced Solid Tumors
- Where
- Celebration, Chicago, Columbus, Denver, Houston, Los Angeles, Nashville, San Francisco, Seattle
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT06526819 - Phase 2Taking peopleA Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)
- Where
- Charleston, Syracuse
- Age
- 18 years and over
- People
- 55
- Run by
- Medical University of South Carolina
See details and how to joinNCT07743190 - Phase 1Taking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Aurora, Charleston, Chicago, Cleveland, Denver, Duarte, Durham, Fairfax, Grand Rapids, Greenville, Houston, Nashville, New York, Providence, San Antonio, San Francisco, Sarasota, St Louis
- Age
- 18 years and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - Early phase 1Taking peopleNeratinib in Combination With Ruxolitinib in Patients With mTNBC
- Where
- Dallas
- Age
- 18 years and over
- People
- 20
- Run by
- Baylor Research Institute
See details and how to joinNCT06008275 - Phase 1/2Taking peopleFirst-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Where
- Aurora, Detroit, Fairfax, Houston, Long Island City, Manhattan, Nashville, Omaha, San Antonio, Sarasota, St Louis
- Age
- 18 years and over
- People
- 218
- Run by
- Accent Therapeutics
See details and how to joinNCT06799065 - Phase 1/2Taking peopleA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Where
- Fairfax, Huntersville, New York, San Antonio
- Age
- 18 years and over
- People
- 499
- Run by
- Arvinas Inc.
See details and how to joinNCT07749586 · EU 2026-525614-57-00 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Princeton
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Fairfax, Grand Rapids, Houston, Pittsburgh, San Antonio, St Louis
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043